Advanced edited magnetic resonance spectroscopy
Developing and evaluating spectral-editing approaches for low-concentration, overlapping metabolite signals, including multi-metabolite methods such as HERMES and HERCULES.
My research develops and applies in vivo magnetic resonance spectroscopy (MRS) to detect and quantify low-concentration metabolites in the living human brain.
Magnetic resonance spectroscopy (MRS) complements MRI by noninvasively measuring chemical concentrations in tissue. My work focuses on improving the acquisition, processing, and interpretation of these measurements, with particular attention to GABA and glutathione.
The work connects technical development with biomedical application: better sequences, more reliable processing, consistent reporting, and collaborative studies designed to establish how measurements behave across people, scanners, and sites.
That question links the methodological, collaborative, and open-science strands of my research.
Developing and evaluating spectral-editing approaches for low-concentration, overlapping metabolite signals, including multi-metabolite methods such as HERMES and HERCULES.
Testing repeatability and reproducibility across sequences, scanners, processing choices, and research sites so that biological interpretation rests on robust measurements.
Leading and contributing to coordinated studies such as Big GABA, which brought together 26 institutions to examine implementation differences in edited MRS.
Developing software and contributing to community standards, including Gannet and BIDS, to support transparent, reusable workflows.
Optimize sequences and experimental choices for target metabolites and anatomical regions.
Improve processing, quality assessment, modeling, and uncertainty-aware interpretation.
Use open formats, software, documentation, and reporting conventions to strengthen the field.